TGF-β affects development and differentiation of human natural killer cell subsets

European Journal of Immunology

Volumn 40, Issue 8, 2010, Pages 2289-2295

  Allan, David S J ^a,b   Rybalov, Basya ^a   Awong, Génève ^b   Zúñiga Pflücker, Juan Carlos ^b   Kopcow, Hernan D ^a,c   Carlyle, James R ^b   Strominger, Jack L ^a  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell differentiation; Innate immunity; NK cells

Indexed keywords

CD16 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CYTOKINE; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BLOOD; BONE MARROW CELL; CELL DIFFERENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INNATE IMMUNITY; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES, BLOCKING; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BONE MARROW; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CYTOKINES; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956111335     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939910     Document Type: Article

References (32)

1. Nagler, A., Lanier, L. L., Cwirla, S. and Phillips, J. H., Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989. 143: 3183-3191.
2. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633-640.
3. Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E. and Caligiuri, M. A., Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001. 97: 3146-3151.
4. Koopman, L. A., Kopcow, H. D., Rybalov, B., Boyson, J. E., Orange, J. S., Schatz, F., Masch, R. et al., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003. 198: 1201-1212.
5. Hanna, J., Bechtel, P., Zhai, Y., Youssef, F., McLachlan, K. and Mandelboim, O., Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J. Immunol. 2004. 173: 6547-6563.
6. Fehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M. and Caligiuri, M. A., CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003. 101: 3052-3057.
7. Ferlazzo, G., Thomas, D., Lin, S. L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A. and Munz, C., The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 2004. 172: 1455-1462.
8. Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K. and Doherty, J. M. et al., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009. 457: 722-725.
9. Vivier, E., Spits, H. and Cupedo, T., Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat. Rev. Immunol. 2009. 9: 229-234.
10. Moffett-King, A., Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002. 2: 656-663.
11. Li, M. O. and Flavell, R. A., TGF-beta: a master of all T cell trades. Cell 2008. 134: 392-404.
12. Fortunel, N. O., Hatzfeld, A. and Hatzfeld, J. A., Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 2000. 96: 2022-2036.
13. Bellone, G., Aste-Amezaga, M., Trinchieri, G. and Rodeck, U., Regulation of NK cell functions by TGF-beta 1. J. Immunol. 1995. 155: 1066-1073.
14. Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R. et al., Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 2003. 100: 4120-4125.
15. Eriksson, M., Meadows, S. K., Wira, C. R. and Sentman, C. L., Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J. Leukoc. Biol. 2004. 76: 667-675.
16. Trotta, R., Col, J. D., Yu, J., Ciarlariello, D., Thomas, B., Zhang, X., Allard, J. et al., TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. J. Immunol. 2008. 181: 3784-3792.
17. Laouar, Y., Sutterwala, F. S., Gorelik, L. and Flavell, R. A., Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 2005. 6: 600-607.
18. Blom, B. and Spits, H., Development of human lymphoid cells. Annu. Rev. Immunol. 2006. 24: 287-320.
19. Chan, A., Hong, D. L., Atzberger, A., Kollnberger, S., Filer, A. D., Buckley, C. D., McMichael, A. et al., CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J. Immunol. 2007. 179: 89-94.
20. Romagnani, C., Juelke, K., Falco, M., Morandi, B., D'Agostino, A., Costa, R., Ratto, G. et al., CD56brightCD16- killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 2007. 178: 4947-4955.
21. Takahashi, E., Kuranaga, N., Satoh, K., Habu, Y., Shinomiya, N., Asano, T., Seki, S. and Hayakawa, M., Induction of CD16+CD56bright NK cells with antitumour cytotoxicity not only from CD16-CD56bright NK Cells but also from CD16-CD56dim NK cells. Scand. J. Immunol. 2007. 65: 126-138.
22. Huntington, N. D., Legrand, N., Alves, N. L., Jaron, B., Weijer, K., Plet, A., Corcuff, E. et al., IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 2009. 206: 25-34.
23. Keskin, D. B., Allan, D. S., Rybalov, B., Andzelm, M. M., Stern, J. N., Kopcow, H. D., Koopman, L. A. and Strominger, J. L., TGFbeta promotes conversion of CD16+peripheral blood NK cells into CD16-NK cells with similarities to decidual NK cells. Proc. Natl. Acad. Sci. USA 2007. 104: 3378-3383.
24. Vosshenrich, C. A., Garcia-Ojeda, M. E., Samson-Villeger, S. I., Pasqualetto, V., Enault, L., Richard-Le Goff, O., Corcuff, E. et al., A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 2006. 7: 1217-1224.
25. Silva, A., Andrews, D. M., Brooks, A. G., Smyth, M. J. and Hayakawa, Y., Application of CD27 as a marker for distinguishing human NK cell subsets. Int. Immunol. 2008. 20: 625-630.
26. Poli, A., Michel, T., Theresine, M., Andres, E., Hentges, F. and Zimmer, J., CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009. 126: 458-465.
27. Hayakawa, Y., Huntington, N. D., Nutt, S. L. and Smyth, M. J., Functional subsets of mouse natural killer cells. Immunol. Rev. 2006. 214: 47-55.
28. Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E. and Walzer, T., Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009. 113: 5488-5496.
29. Gregoire, C., Chasson, L., Luci, C., Tomasello, E., Geissmann, F., Vivier, E. and Walzer, T., The trafficking of natural killer cells. Immunol. Rev. 2007. 220: 169-182.
30. Yu, J., Mao, H. C., Wei, M., Hughes, T., Zhang, J., Park, I. K., Liu, S. et al., CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 2010. 115: 274-281.
31. Dulphy, N.,Haas, P., Busson,M., Belhadj, S., Peffault de Latour, R., Robin, M., Carmagnat, M. et al., An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J. Immunol. 2008. 181: 2227-2237.
32. La Motte-Mohs, R. N., Herer, E. and Zuniga-Pflucker, J. C., Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 2005. 105: 1431-1439.